# The Potential Role of 18F-NaF PET/CT in Diagnosing Cardiac Amyloidosis

> **NCT04146480** · NA · UNKNOWN · sponsor: **Tel-Aviv Sourasky Medical Center** · enrollment: 40 (estimated)

## Conditions studied

- Cardiac Amyloidosis

## Interventions

- **DIAGNOSTIC_TEST:** F18-NaF PET/CT

## Key facts

- **NCT ID:** NCT04146480
- **Lead sponsor:** Tel-Aviv Sourasky Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-07-01
- **Primary completion:** 2018-07-31
- **Final completion:** 2020-07-24
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2019-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04146480

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04146480, "The Potential Role of 18F-NaF PET/CT in Diagnosing Cardiac Amyloidosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04146480. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*